We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Posted on January 29, 2025
The world-wide pandemic involving SARS-CoV2 in which high infectivity and pathogenesis necessitated the critical need for rapid and accurate preclinical modeling of this new virus. Unfortunately, the species-restricted tropism of the CoV2 spike protein towards human and not mouse ACE2, seriously hampered the ability to understand pathogenesis and potential efficacy of potential therapeutics and vaccines. Vaccine responses are particularly imperative given the likely need for continuous vaccine administration and viral evasion processes. This barrier necessitated the development of genetically altered mouse models or adapting the virus to infect murine cells.
-William Murphy, Cordelia Dunai and Smita S. Iyer
The immune responses underlying SARS-CoV2 infection are complex as are the immunopathology associated with infection and resolution in which multiple organs and tissues are affected. This is highlighted by the occurrence of prolonged pathology and symptoms termed “Long Covid” well after resolution of infection and also coupled with the high mutation rate of the virus. Preclinical models allow for mechanistic dissection of the pleiotropic effects of the virus as well as vaccine responses. These can include mouse models but also involve non-human primate models, all of which have advantages but limitations that must be considered when extrapolating to humans. Preclinical models may also include in vitro modeling components.
Source: https://www.frontiersin.org/research-topics/58261/immune-studies-of-sars-cov2-and-vaccines-using-preclinical-modeling